Located in the Life Sciences Center in Seattle, WA and having a management team with diverse academic and company sytart-up and management experience, Compliment Corporation works in the space of oncology therapeutics. Addressing the improvement of cancer treatment by increasing the effectiveness of cancer drugs while also reducing the toxicities associated with standard chemotherapy treatment, the companyâs technology targets immune signaling molecules and tight junction architecture proteins. The effort is to remodel tumor cells allowing easy killing by monoclonal antibodies and chemotherapeutics: optimizing production of the small proteins that have these effects
